Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 544

1.

Differentiating ischemic stroke subtypes: risk factors and secondary prevention.

Kirshner HS.

J Neurol Sci. 2009 Apr 15;279(1-2):1-8. doi: 10.1016/j.jns.2008.12.012. Epub 2009 Jan 29. Review.

PMID:
19185319
2.

Ischemic stroke in patients receiving aspirin.

Pujol Lereis VA, Ameriso S, Povedano GP, Ameriso SF.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):868-72. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.009. Epub 2011 Jun 23.

PMID:
21703876
3.

Ischemic stroke: prevalence of modifiable risk factors in male and female patients in Pakistan.

Khan NI, Naz L, Mushtaq S, Rukh L, Ali S, Hussain Z.

Pak J Pharm Sci. 2009 Jan;22(1):62-7.

PMID:
19168423
4.

An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.

Nowacki P, Porebska A, Bajer-Czajkowska A, Zywica A, Koziarska D, Podbielski J.

Ann Acad Med Stetin. 2007;53(2):14-9.

PMID:
18557372
5.

Secondary prevention of stroke: a practical guide to drug treatment.

Koennecke HC.

CNS Drugs. 2004;18(4):221-41. Review.

PMID:
15015903
6.

Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?

Talelli P, Greenwood RJ.

Ther Adv Cardiovasc Dis. 2008 Oct;2(5):387-405. doi: 10.1177/1753944708093411. Epub 2008 Aug 21. Review.

PMID:
19124436
7.

Preventing recurrent ischemic stroke: a 3-step plan.

Cohen SN.

J Fam Pract. 2005 May;54(5):412-22. Review. No abstract available.

PMID:
15865898
8.

Secondary prevention of ischemic cerebrovascular disease. What is the evidence?

Paraskevas KI, Daskalopoulou SS, Daskalopoulos ME, Liapis CD.

Angiology. 2005 Sep-Oct;56(5):539-52. Review.

PMID:
16193192
9.

Therapeutic interventions for prevention of recurrent ischemic stroke.

Kirshner HS.

Am J Manag Care. 2008 Jun;14(6 Suppl 2):S212-26. Review.

10.

The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM; PERFORM Study Investigators.

Cerebrovasc Dis. 2009;27(6):608-13. doi: 10.1159/000216835. Epub 2009 Apr 30.

PMID:
19407444
11.

Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study.

Béjot Y, Osseby GV, Gremeaux V, Durier J, Rouaud O, Moreau T, Giroud M.

J Neurol Sci. 2009 Dec 15;287(1-2):84-8. doi: 10.1016/j.jns.2009.08.062. Epub 2009 Sep 19.

PMID:
19766250
12.

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.

Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology.

Stroke. 2006 Feb;37(2):577-617.

13.

The emergency department: first line of defense in preventing secondary stroke.

Ovbiagele B.

Acad Emerg Med. 2006 Feb;13(2):215-22. Epub 2006 Jan 25.

14.

Standard medical management in secondary prevention of ischemic stroke in China (SMART).

Peng B, Zhu Y, Cui L, Ni J, Xu W, Zhou L, Yao M, Chen L, Wang J, Wang Y, Pu C; SMART Study Group.

Int J Stroke. 2011 Oct;6(5):461-5. doi: 10.1111/j.1747-4949.2011.00648.x.

PMID:
21951412
15.

Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study.

Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR.

Stroke. 2006 Oct;37(10):2493-8. Epub 2006 Aug 24.

16.

Prevention of recurrent ischemic stroke.

Dickerson LM, Carek PJ, Quattlebaum RG.

Am Fam Physician. 2007 Aug 1;76(3):382-8. Review.

17.

Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.

Fuentes B, Martínez-Sánchez P, Díez-Tejedor E.

Cerebrovasc Dis. 2009;27 Suppl 1:126-33. doi: 10.1159/000200450. Epub 2009 Apr 3. Review.

PMID:
19342842
18.

Dyslipidemia as a risk factor for ischemic stroke.

Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

Curr Top Med Chem. 2009;9(14):1291-7. Review.

PMID:
19849661
19.

Primary and secondary prevention of ischemic stroke.

Paciaroni M, Bogousslavsky J.

Eur Neurol. 2010;63(5):267-78. doi: 10.1159/000285183. Epub 2010 Mar 27. Review.

20.

Stroke prevention in diabetes and obesity.

Kurukulasuriya LR, Govindarajan G, Sowers J.

Expert Rev Cardiovasc Ther. 2006 Jul;4(4):487-502. Review.

PMID:
16918267
Items per page

Supplemental Content

Write to the Help Desk